Get started
DarioHealth Corp.DarioHealth Corp.DarioHealth Corp.

DarioHealth Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

DRIO chart


Full chart

DRIO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪24.18 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.9721 USD
Net income (FY)
‪−54.86 M‬ USD
Revenue (FY)
‪20.35 M‬ USD
Shares float
‪29.75 M‬
Beta (1Y)
1.72

Employees


Employees (FY)
276
Change (1Y)
+35 +14.52%
Revenue / Employee (1Y)
‪73.74 K‬ USD
Net income / Employee (1Y)
‪−198.77 K‬ USD

About DarioHealth Corp.


Sector
Health Technology
Industry
Medical Specialties
CEO
Erez Raphael
Website
dariohealth.com
Headquarters
New York
Founded
2011
FIGI
BBG003V5P7K2
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth serves customers globally. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

DRIO news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DRIO is 0.5994 USD — it has increased by 1.61% in the past 24 hours. Watch DarioHealth Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange DarioHealth Corp. stocks are traded under the ticker DRIO.
DRIO stock has fallen by −10.00% compared to the previous week, the month change is a −24.77% fall, over the last year DarioHealth Corp. has showed a −67.77% decrease.
We've gathered analysts' opinions on DarioHealth Corp. future price: according to them, DRIO price has a max estimate of 5.00 USD and a min estimate of 1.00 USD. Watch DRIO chart and read a more detailed DarioHealth Corp. stock forecast: see what analysts think of DarioHealth Corp. and suggest that you do with its stocks.
DRIO reached its all-time high on May 9, 2016 with the price of 118.0000 USD, and its all-time low was 0.5600 USD and was reached on Jan 29, 2025. View more price dynamics on DRIO chart.
See other stocks reaching their highest and lowest prices.
DRIO stock is 9.93% volatile and has beta coefficient of 1.72. Track DarioHealth Corp. stock price on the chart and check out the list of the most volatile stocks — is DarioHealth Corp. there?
Today DarioHealth Corp. has the market capitalization of ‪24.18 M‬, it has decreased by −8.59% over the last week.
Yes, you can track DarioHealth Corp. financials in yearly and quarterly reports right on TradingView.
DarioHealth Corp. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
DRIO earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.22 USD resulting in a −15.38% surprise. The estimated earnings for the next quarter are −0.33 USD per share. See more details about DarioHealth Corp. earnings.
DarioHealth Corp. revenue for the last quarter amounts to ‪7.42 M‬ USD, despite the estimated figure of ‪7.40 M‬ USD. In the next quarter, revenue is expected to reach ‪7.39 M‬ USD.
DRIO net income for the last quarter is ‪−9.92 M‬ USD, while the quarter before that showed ‪−3.37 M‬ USD of net income which accounts for −194.34% change. Track more DarioHealth Corp. financial stats to get the full picture.
No, DRIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 4, 2025, the company has 276.00 employees. See our rating of the largest employees — is DarioHealth Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DarioHealth Corp. EBITDA is ‪−52.68 M‬ USD, and current EBITDA margin is −249.79%. See more stats in DarioHealth Corp. financial statements.
Like other stocks, DRIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DarioHealth Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DarioHealth Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DarioHealth Corp. stock shows the sell signal. See more of DarioHealth Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.